144 ·Filed May 13, 2026

WRBY

Warby Parker Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago SEC0001968582-26-000439
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine director sale — no material signal. Monitor for any Form 4 filings confirming execution, but the size and insider status suggest no bearish read-through. The stock's 70% analyst bullish consensus and recent insider selling pattern are consistent with normal portfolio management.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
WRBY ▼ -8.62% at T+60d
NEUTRAL call ✗ call lost -8.62% · α vs SPY -12.20% · entry $28.90 → $26.41
Entry anchored
May 13, 2026
via day open
T+1d
-0.59%
call -0.59% · α +0.64%
$28.73
settled 5mo ago
T+5d
-15.22%
call -15.22% · α -14.51%
$24.50
settled 5mo ago
T+20d
-8.44%
call -8.44% · α -7.58%
$26.46
settled 4mo ago
T+60d
-8.62%
call -8.62% · α -12.20%
$26.41
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Director Bradley Singer filed a Form 144 to sell 25,000 Class A common shares (~$674K at current price) via J.P. Morgan Securities. The shares were acquired via open-market purchase on 8/13/2024, and the trust already sold 15,793 shares on 3/4/2026. This is a modest sale by a director, not a C-suite insider, and represents a small fraction of Singer's total holdings (over 107M shares beneficially owned). The filing signals intent to sell but is not a completed transaction.

Key Facts

  • Director Bradley Singer (not CEO/CFO) filed Form 144 to sell 25,000 Class A shares.
  • Estimated proceeds: ~$674K based on current price; shares acquired via open market on 8/13/2024.
  • Singer beneficially owns over 107M shares, making this sale ~0.02% of holdings.
  • A prior trust sale of 15,793 shares occurred on 3/4/2026.
  • Recent insider activity (30d) shows 3 sells totaling $1.8M, consistent with routine diversification.

Financial Impact

~$674K sale by director; immaterial relative to $3.3B market cap.

insider ownership

Risk Factors

  • If Singer accelerates selling beyond this filing, it could signal reduced conviction.
  • Form 144 is intent only — sale may not execute; no immediate market impact expected.

Market Snapshot

Exchange
NYSE
Sector
Ophthalmic Goods
Analyst Consensus
70% bullish (20 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001968582-26-000439
Document: 0001968582-26-000439-index.html0001968582-26-000439
Document: 0001968582-26-000439.txt0001968582-26-000439
9 reports for WRBY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for WRBY — sortable, filterable
TypeNow
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$29.32 $26.96▼ −8.05%▼ −10.29%$27.78 (−5.25%)
Jul 3, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$29.26 $26.02▼ −11.07%▼ −10.66%$27.78 (−5.06%)
Jun 14, 2026
15w ago
Institutional Cluster
MIXED ★ 4/10
$26.38 $27.41▲ +3.90%▲ +4.65%$27.78 (+5.31%)
Jun 12, 2026
15w ago
144
NEUTRAL ★ 2/10
$26.38 $27.41▲ +3.90%▲ +4.65%$27.78 (+5.31%)
Jun 11, 2026
16w ago
Institutional Cluster
MIXED ★ 4/10
$25.86 $29.32▲ +13.38%▲ +11.49%$27.78 (+7.42%)
May 21, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$25.09 $26.12▲ +4.11%▲ +5.52%$27.78 (+10.72%)
May 13, 2026
20w ago
144
NEUTRAL ★ 3/10
$28.90 $26.46▼ −8.44%▼ −7.58%$27.78 (−3.88%)
Mar 4, 2026
30w ago
Insider Cluster
NEUTRAL ★ 4/10
$27.36 $21.41▼ −21.75%▼ −17.33%$27.78 (+1.54%)
Feb 26, 2026
31w ago
8-K
BULLISH ★ 8/10
$25.65 $21.99▼ −14.27%▼ −7.87%$27.78 (+8.30%)
Showing 9 of 9

US Market Status

Market Open — Closes in 6h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access